IFNG and Alzheimer disease: Compared with AD deficient patients, those with AR deficiency were more likely to suffer from disseminated life-threatening infections, were less responsive to IFN-γ supplement therapy, and had higher mortality; these findings were similar to those of an earlier study (75).